eurecam e-Newsletter
Year 1 Issue 4 December 2010
In this issue:
FACEBOOK FOR EURECA-m : Options and Appraisal
Kidney / Heart and Vessels Meeting from Ziad A. Massy and Christian Noel
Useful Links and Important Events
EURECA-m Board Members

Carmine Zoccali, Italy (EURECA-m Chairman)

Adrian Covic, Romania (EURECA-m Secretary)
David Goldsmith, UK (Editor in Chief of EURECA-m Newsletter)
Gérard Michel London, France (ERA-EDTA President)
Bengt Lindholm, Sweden
Alberto Martinez Castelao, Spain
Gultekin Suleymanlar, Turkey
Danilo Fliser, Germany
Andrzej Wiecek, Poland (liaison with National Societies of Nephrology)
Ziad A. Massy, France
Alberto Ortiz Arduan, Spain (Auditor)
Epidemiology and Biostatistics Consultants
Kitty J Jager, The Netherlands
Friedo W Dekker, The Netherlands
Giovanni Tripepi, Italy
Cecile Couchoud, France
May 20-22, 2011 - Groningen, The Netherlands
EURECA-m News and Best wishes for the Holiday Season 
FACEBOOK FOR EURECA-m : Options and Appraisal
The main scope of EURECA-m is promoting scientific research in the area of cardiovascular and renal medicine.  As already announced in previous newsletters, the first concrete initiative of EURECA-m working group is

to create an ESRD Cardiovascular Research Registry. This registry aims at a systematic collection of 24h ABPM recordings, Echocardiography and Pulse Wave Velocity (PWV) measurements, demographic and clinical data and incident clinical outcomes. The Registry also aims  at  establishing  peripheral (centre-based) Biobanksat  in  some of the centres involved in the initiative.
The starting up of this registry implies various problems related to data standardization and coordination. After  a long preparatory phase, the Registry is now entering a pilot phase.  On November 11th-12th in Vienna the first organizational meeting was held. In this meeting leading experts in echocardiography, ambulatory BP monitoring and PWV gave state of art presentations on the same techniques and   outlined   specific recommendation for standardization, data validation and collection. The Registry adopted three validation centres (Pulse Wave Velocity in Paris, coordinated by Prof. Gérard Michel London; 24h ABPM in Milan coordinated by Prof. Gianfranco Parati; Echocardiography in Naples, coordinated by Prof. Giovanni De Simone).   Practical aspects on how to send data to validation centres and to the EURECA-m Registry   were discussed and the group came up with specific decisions.  In the pilot phase, data of prevalent and incident patients will be collected in 11 European centres. Each centre will enrol patients at a rate of about 10 prevalent patients/month plus all incident patients.  By October 2011, the Registry    will already be the largest repository of Echocardiographic, 24h ABPM   and PWV in ESRD and will allow new, solid analyses on the prognostic implication of these methods for risk stratification of ESRD patients.  EURECA-m also appointed a special board of epidemiologists and biostatisticians that will provide methodological input for observational studies. Thus, in about 1 year  the EURECA-m Registry  will  become a valuable resource for investigators in the field. We aim at a gradual growth and, after the pilot phase, the Registry will be extended  to other European centres interested in joining.

Read more

The man behind the world's largest social network has been named Time's Person of the Year.
Time magazine announced today that its editors picked Facebook CEO Mark Zuckerberg for the

annual honor, beating out runners-up Julian Assange, the man behind the internationally controversial WikiLeaks, and the "Tea Party" (which needs no explanation or introduction, just incredulity or indulgence). Time magazine credited Zuckerberg with connecting more than half a billion people with through Facebook and mapping the social relations among them. And because Facebook's 26-year-old CEO also is credited with creating a new system of exchanging information that is changing how people live their lives, he was named Person of the Year. Oh, and there's just been released a Hollywood film about it all, too.
I would like us in EURECA-m to consider using social / business networking sites to allow us more easily, more swiftly, and above all more interactively to communicate with one-another, allowing for true inter-connectivity, and cross-fertilisation of ideas and support. It's a noble, valuable aim, but one we must work through together to achieve these aims without unintended consequences.
Facebook (for those not in the know) is a social network service and website launched in February 2004 that is operated and privately owned by Facebook, Inc.  As of July 2010 Facebook has more than 500 million active users. Users may create a personal profile, add other users as friends and exchange messages, including automatic notifications when they update their profile. Additionally, users may join common interest user groups, organized by workplace, school, or college, or other characteristics. Facebook allows anyone who declares themselves to be at least 13 years old to become a registered user of the website.
A January 2009 study ranked Facebook as the most used social network by worldwide monthly active users, followed by MySpace. In the business arena, PipL and LinkedIn are popular. Amongst a great number of other things, both Facebook and LinkedIn offer you the facility to setup your own groups or join existing ones, and allow like-minded people to join in and share ideas, interact, and do business. But each type of group has its own features and functionality, which is closely linked to the way both social networking platforms came up.

Read more

return to top

Kidney / Heart and Vessels Meeting (Fez, Morocco, February 11 to 13, 2011) from Ziad A. Massy and Christian Noel

For this seventh French-Moroccan meeting, we would once again focus on translational researches. We have chosen to consider with our Moroccan friends cardiovascular problems that we experience every day in our patients with chronic kidney disease. For this, we have set a large nephrology-cardiovascular interface program between the Moroccan Society of Kidney Disease, Nephrologists in Northern France, INSERM, ERI12 in Amiens and the support by Roche. This program includes prestigious nephrology and cardiology experts of the selected cardio-renal topics, and should allow us to take the time to explore these themes in two and a half days.

Ziad A. Massy and Christian Noel


return to top

Ziad A. Massy
Ziad A Massy
Christian Noel
Christian Noel
Useful Links and Important Events

4th Meeting Uremic Toxins and Cardiovascular Disease

This meeting is endorsed by ERA-EDTA

May 20-22, 2011 - Groningen, The Netherlands




return to top
EURECA-m Website: